RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion Injectable Peptides: Out of the Back Alley and Into the Light? Berkley Lifesciences Compounded "semaglutide" is not FDA approved semaglutide.com In 2023, the FDA deemed 19 peptides too unsafe to be dispensed by compounding pharmacies. Now, under RFK Jr., the agency is poised to reverse itself despite the fact that few FDA Issues Warning: Compounding Certain Bulk Drug Substances May Pose Major Legal and Patient Safety Risks Lengea BPC 157 Banned: Key Facts on the Latest FDA Decision